Healthcare
Studies from the United States and Canada advance knowledge in healthcare research
Published in Women's Health Weekly, July 13th, 2006
Study 1: Premenstrual dysphoric disorder responds to a limited serotonin reuptake inhibitor dosing strategy.
"Symptoms of premenstrual dysphoric disorder (PMDD) respond to serotonin reuptake inhibitors when treatment is limited to 14 days of the menstrual cycle. Many women have less than a week of symptoms, and shorter treatment intervals would further reduce medication exposure and costs," stated investigators at Yale University.
K.A. Yonkers and colleagues explained, "Twenty women with PMDD were randomly assigned to either paroxetine CR or placebo...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
More Articles from Women's Health Weekly
- Breast Cancer
Severity of breast cancer at diagnosis is associated with race - Cardiovascular Disease
Obesity-related cardiovascular risk factors may be improved by increased fruit consumption - Gastroenterology
Gastroesophageal reflux is associated with even moderate weight increase in women - Lung Cancer
Lung cancer screening with pulmonary function tests should consider gender differences - Osteoporosis
Natural health products for osteoporosis prevention and treatment are focus of review - Adrenal Cortical Cancer
Case of adrenal cortical carcinoma metastatic to the breast reported - More from this issue of Women's Health Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
